Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (46)

2024

  1. Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis

    Journal of Neurochemistry, Vol. 168, Núm. 5, pp. 744-759

2023

  1. Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

    Antioxidants, Vol. 12, Núm. 2

  2. Lipid Adaptations against Oxidative Challenge in the Healthy Adult Human Brain

    Antioxidants, Vol. 12, Núm. 1

  3. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916

  4. Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity

    The Journal of clinical investigation, Vol. 133, Núm. 10

2022

  1. A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers

    Disease models & mechanisms, Vol. 15, Núm. 8

  2. Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

    Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258

  3. Cardiac fibroblasts display endurance to ischemia, high ROS control and elevated respiration regulated by the JAK2/STAT pathway

    FEBS Journal, Vol. 289, Núm. 9, pp. 2540-2561

  4. Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model

    Neuropathology and Applied Neurobiology, Vol. 48, Núm. 1

  5. Selective brain regional changes in lipid profile with human aging

    GeroScience, Vol. 44, Núm. 2, pp. 763-783

2021

  1. Age-related changes in lipidome of rat frontal cortex and cerebellum are partially reversed by methionine restriction applied in old age

    International Journal of Molecular Sciences, Vol. 22, Núm. 22

  2. Cell stress induces mislocalization of transcription factors with mitochondrial enrichment

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  3. Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 4, pp. 544-563

  4. Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

    Brain Communications, Vol. 3, Núm. 3

  5. New insights into human prefrontal cortex aging with a lipidomics approach

    Expert Review of Proteomics, Vol. 18, Núm. 5, pp. 333-344

  6. The causal role of lipoxidative damage in mitochondrial bioenergetic dysfunction linked to alzheimer’s disease pathology

    Life, Vol. 11, Núm. 5

2020

  1. Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

    Neurotherapeutics, Vol. 17, Núm. 1, pp. 269-281

  2. Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy

    Brain

2019

  1. Altered dynein axonemal assembly factor 1 expression in C-boutons in bulbar and spinal cord motor-neurons in sporadic amyotrophic lateral sclerosis

    Journal of Neuropathology and Experimental Neurology, Vol. 78, Núm. 5, pp. 416-425

  2. Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

    Neurotherapeutics, Vol. 16, Núm. 4, pp. 1167-1182